New York, United States, October 26th, 2026, Chainwire Ritual Chain turns AI agents into persistent economic actors that control their own wallets, onchain identity, and private state. Ritual, a lab
New York, United States, October 26th, 2026, Chainwire Ritual Chain turns AI agents into persistent economic actors that control their own wallets, onchain identity, and private state. Ritual, a lab
Veteran podcast is hosted by Charles Chou, a Marine Corps veteran, and produced by VeteranDegrees.com, a free education and career-planning resource for veterans, service members, and military families United States,
KodyGas extends its services to include air conditioning following F-gas certification, covering homes and small businesses across Sheffield, Rotherham, Doncaster and Barnsley. United Kingdom, 26th Oct 2026 – KodyGas Boiler
Artist plans to launch the album and graphic novel “Robot Dream” on November 20 and start a world tour on January 1 in Rio de Janeiro. United States, 26th Oct
Olathe, KS 66061, United States, 26th Oct 2026 – Midwest Tree, a tree service in Lenexa, Kansas, has passed 100 Google reviews. The milestone matters for a locally owned company
MUGGIÒ, Italy, October 24th, 2026, FinanceWire Tecnover, the Italian manufacturer of professional spray-painting equipment, is celebrating more than four decades of innovation in spray-painting technology. Founded in 1984, the family-run
Haifa, Israel, October 26th, 2026, FinanceWire Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine. Partnership combines Pluri’s proprietary cell technology and clinical-development experience
MUGGIÒ, Italy, October 24th, 2026, FinanceWire Tecnover, the Italian manufacturer of professional spray-painting equipment, is celebrating more than four decades of innovation in spray-painting technology. Founded in 1984, the family-run
Haifa, Israel, October 26th, 2026, FinanceWire Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine. Partnership combines Pluri’s proprietary cell technology and clinical-development experience